KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation
Cancer Science · 2024-05 · 115 (5) · 1520-1535
DOI: 10.1111/cas.16144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 12.03.2024. Verfasst von Kazuya Kato und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan. Hauptthemen laut MEDLINE: Cell Proliferation, Colonic Neoplasms, Endothelial Cells, Kallikreins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Tumor endothelial cells (TECs), which are thought to be structurally and functionally different from normal endothelial cells (NECs), are increasingly attracting attention as a therapeutic target in hypervascular malignancies. Although colorectal liver metastasis (CRLM) tumors are hypovascular, inhibitors of angiogenesis are a key drug in multidisciplinary therapy, and TECs might be involved in the development and progression of cancer. Here, we analyzed the function of TEC in the CRLM tumor microenvironment. We used a murine colon cancer cell line (CT26) and isolated TECs from CRLM tumors. TECs showed higher proliferation and migration than NECs. Coinjection of CT26 and TECs yielded rapid tumor formation in vivo. Immunofluorescence analysis showed that coinjection of CT26 and TECs increased vessel formation and Ki‐67 + cells. Transcriptome analysis identified kallikrein‐related peptide 10 (KLK10) as a candidate target. Coinjection of CT26 and TECs after KLK10 downregulation with siRNA suppressed tumor formation in vivo. TEC secretion of KLK10 decreased after KLK10 downregulation, and conditioned medium after KLK10 knockdown in TECs suppressed CT26 proliferative activity. Double immunofluorescence staining of KLK10 and CD31 in CRLM tissues revealed a significant correlation between poor prognosis and positive KLK10 expression in TECs and tumor cells. On multivariate analysis, KLK10 expression was an independent prognostic factor in disease‐free survival. In conclusion, KLK10 derived from TECs accelerates colon cancer cell proliferation and hematogenous liver metastasis formation. KLK10 in TECs might offer a promising therapeutic target in CRLM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
ORCID-Profile: Takehiro Noda, Shogo Kobayashi, Daisaku Yamada, Yoshito Tomimaru, Hidenori Takahashi, Hidetoshi Eguchi
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kato, K., Noda, T., Kobayashi, S., Sasaki, K., Iwagami, Y., Yamada, D., Tomimaru, Y., Takahashi, H., Uemura, M., Asaoka, T., Shimizu, J., Doki, Y., & Eguchi, H. (2024). KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation. Cancer Science, 115(5), 1520-1535. https://doi.org/10.1111/cas.16144
Vancouver
Kato K, Noda T, Kobayashi S, Sasaki K, Iwagami Y, Yamada D, et al. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation. Cancer Science. 2024;115(5):1520-1535. doi:10.1111/cas.16144
BibTeX
@article{Kato2024,
author = {Kato, Kazuya and Noda, Takehiro and Kobayashi, Shogo and Sasaki, Kazuki and Iwagami, Yoshifumi and Yamada, Daisaku and Tomimaru, Yoshito and Takahashi, Hidenori and Uemura, Mamoru and Asaoka, Tadafumi and Shimizu, Junzo and Doki, Yuichiro and Eguchi, Hidetoshi},
title = {KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {5},
pages = {1520--1535},
doi = {10.1111/cas.16144}
}
EUVIMED